Biotech China 2014

View Profile


Grant Support

Start year End year Title Source Position
1. 2010 2012 Investigator NIH Abrogation of Human CD59 Function for Immune Cancer Therapy
2. 2011 Investigator NIH Atherogenic roles of complement membrane attack complex
3. 2011 Investigator Leukemia $ Lymphoma Society To develop a therapeutic CD59 inhibitor for treating B-cell malignancies
4. 2011 Investigator NIH A universal model for cell ablation
5. 2011 Investigator NIH Hemolysis-associated sudden death and/or fatal pulmonary hypertension
6. 2010 Investigator American Heart Association Inhibition of complement activation for the treatment of atherosclerosis
7. 2008 2010 Investigator Harvard University Technology Development Accelerator Fund Abrogation of Human CD59 Function for Immune Cancer Therapy
8. 2005 2010 Investigator NIH Towards a Mouse Model of Complement-Mediated Diseases
9. 2004 2008 Investigator American Heart Association# 0435483N Role of Complement in the Pathogenesis of Atherosclerosis Scientific Development Program


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.